Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-03-07

Clinical Trial Update: AV-23-001 AVAVA MIRIA Pilot Study [NA]

View source ↗

Summary

AVAVA, Inc. reports that the AVAVA MIRIA (AV-23-001) pilot study is currently active but not recruiting, with conditions including wrinkles, acne scars, pigment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AVAVA MIRIA

Snippet

Sponsor: AVAVA, Inc. | Conditions: Wrinkle, Acne Scars - Mixed Atrophic and Hypertrophic | NA | Status: ACTIVE_NOT_RECRUITING